- Home
- CNMD vs RXRX Comparison
CNMD vs RXRX Comparison
Compare CNMD & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNMD
- RXRX
- Stock Information
- Founded
- CNMD 1970
- RXRX 2013
- Country
- CNMD United States
- RXRX United States
- Employees
- CNMD N/A
- RXRX N/A
- Industry
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- CNMD Health Care
- RXRX Health Care
- Exchange
- CNMD Nasdaq
- RXRX Nasdaq
- Market Cap
- CNMD 1.7B
- RXRX 2.4B
- IPO Year
- CNMD 1987
- RXRX 2021
- Fundamental
- Price
- CNMD $52.91
- RXRX $4.83
- Analyst Decision
- CNMD Hold
- RXRX Buy
- Analyst Count
- CNMD 5
- RXRX 4
- Target Price
- CNMD $59.80
- RXRX $7.25
- AVG Volume (30 Days)
- CNMD 322.7K
- RXRX 16.3M
- Earning Date
- CNMD 10-29-2025
- RXRX 11-05-2025
- Dividend Yield
- CNMD 1.51%
- RXRX N/A
- EPS Growth
- CNMD 12.82
- RXRX N/A
- EPS
- CNMD 3.54
- RXRX N/A
- Revenue
- CNMD $1,326,244,000.00
- RXRX $64,596,000.00
- Revenue This Year
- CNMD $6.73
- RXRX $24.09
- Revenue Next Year
- CNMD $5.45
- RXRX $20.99
- P/E Ratio
- CNMD $14.94
- RXRX N/A
- Revenue Growth
- CNMD 3.94
- RXRX 30.14
- 52 Week Low
- CNMD $46.00
- RXRX $3.79
- 52 Week High
- CNMD $78.19
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- CNMD 47.69
- RXRX 45.88
- Support Level
- CNMD $52.35
- RXRX $4.51
- Resistance Level
- CNMD $54.12
- RXRX $5.05
- Average True Range (ATR)
- CNMD 1.42
- RXRX 0.22
- MACD
- CNMD -0.19
- RXRX 0.03
- Stochastic Oscillator
- CNMD 19.26
- RXRX 63.33
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.